Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms

Pain

Volumn 93, Issue 3, 2001, Pages 303-315

  Johanek, Lisa M ^a   Heitmiller, Dwayne R ^a   Turner, Michelle ^a   Nader, Nicole ^a   Hodges, Jim ^a   Simone, Donald A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Hyperalgesia; Pain; Rats; WIN 55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; CANNABINOID 1 RECEPTOR; CAPSAICIN; RIMONABANT;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG MECHANISM; ENANTIOMER; HYPERALGESIA; MALE; MECHANICAL STIMULATION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NOCICEPTION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; SPINAL ANESTHESIA; TASK PERFORMANCE; THERMAL STIMULATION;

ANALGESICS; ANIMALS; CANNABINOIDS; CAPSAICIN; HYPERALGESIA; MALE; MORPHOLINES; NAPHTHALENES; NEURONS, AFFERENT; PAIN MEASUREMENT; PERIPHERAL NERVES; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SPINAL CORD;

EID: 0034890340     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(01)00336-0     Document Type: Article

References (78)

1. Molecular neurobiology of the cannabinoid receptor
2. Co-expression of vanilloid 1 and cannabinoid 1 receptors in nociceptive primary sensory neurons
3. Neurogenic hyperalgesia: The search of the primary cutaneous afferent nerve fibers that contribute to capsaicin-induced pain and hyperalgesia
4. 9-nor-9b-Hydroxyhexahydrocanninol, a cannabinoid with potent antinociceptive activity: Comparison with morphine
5. 9-tetrahydrocannabinol in the rat and mouse
6. Control of pain initiation by endogenous cannabinoids
7. Vascular and sensory responses of human skin to mild injury after topical treatment with capsaicin
8. The capsaicin receptor: A heat-activated ion channel in the pain pathway
9. Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism
10. The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice
11. Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities
12. Heat and mechanical hyperalgesia induced by capsaicin. Cross modality threshold modulation in human C nociceptors
13. Cannabinoids modulate potassium current in hippocampal neurons
14. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
15. A note on a simple apparatus for detecting neurological deficit in rats and mice
16. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palitoylethanolamide
17. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors
18. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
19. Enhanced withdrawal responses to heat and mechanical stimuli following intraplantar injection of capsainin in rats
20. Experimental evidence on the nature of cutaneous hyperalgesia
21. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
22. WIN 55,212-2 acts peripherally via the CB1 receptor to reverse carrageenan-induced thermal hyperalgesia in rats
23. Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes
24. Cannabinoid receptor localization in the brain
25. The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain
26. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: Fluorescence studies
27. Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: A double-label in situ hybridization study
28. Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2
29. Cannabinoid modulation of wide dynamic range neurons in the lumbar horn of the rat by spinally administered WIN 55,212-2
30. Intrathecal cannabinoid administration suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in rat spinal cord: Comparison with morphine
31. Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord
32. Inhibition of neuroblastoma adenylyl cyclase by cannabinoid and nantradol compounds
33. Pharmacology of cannabinoid receptors
34. The antihyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain
35. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles
36. Cannabinoids attenuate capsaicin-evoked hyperalgesia through the peripheral CB1 cannabinoid receptor
37. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation
38. 9-tetrahydrocannbinol (THC)
39. Responses of single nerve fibers to capsaicin applied to the skin
40. Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures
41. A preliminary procedure for the evaluation of central nervous system depressants
42. 9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: A peripheral cannabinoid action
43. The effect of capsaicin on the response characteristic of human C-polymodal nociceptors
44. Neurogenic hyperalgesia: Psychophysical studies of underlying mechanisms
45. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin
46. Experiments relating to cutaneous hyperalgesia and its spread through somatic nerves
47. The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats
48. Spinal and supraspinal components of cannabinoid-induced antinociception
49. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: Evidence supporting periaqueductal gray involvement
50. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells
51. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
52. An examination of the central sites of action of cannabinoid-induced antinociception in the rat
53. Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: Correlation between electrophysiological and antinociceptive effects
54. Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla
55. Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections
56. Spinal cannabinoids are anti-allodynic in rats with persistent inflammation
57. Structure of a cannabinoid receptor: Functional expression of the cloned cDNA
58. N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation
59. Molecular characterization of a peripheral receptor for cannabinoids
60. 2+ channels in a neuronal expression system
61. The evidence for the existence of cannabinoid receptors
62. Distribution and phenotype of cannabinoid type one receptor-expressing neurons in the trigeminal ganglion of the rat
63. Antihyperalgesic effects of spinal cannabinoids
64. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
65. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
66. Actions of cannabinoid receptor ligands on rat cultured sensory neurones: Implications for antinociception
67. CB1 receptor localization in rat spinal cord and roots, dorsal root ganglion, and peripheral nerve
68. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures
69. Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin
70. Anti-edema and analgesic properties of delta-9-tetrahydrocannabinol (THC)
71. Cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses
72. A pharmacological approach to elucidation of the role of different nerve fibers and receptor endings in mediation of pain
73. Selective excitation by capsaicin of mechano-heat sensitive nociceptors in rat skin
74. The cloned capsaicin receptor integrates multiple pain-producing stimuli
75. Suppression of noxious stimulus-evoked expression of fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist
76. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
77. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons
78. The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat